Skip to content

3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia

CompletedNot applicableNCT06314152
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study was designed to compare the outcome of 3 point with 1 point lightweight mesh fixation in TAPP surgery for patients with inguinal hernia. The main outcome include seroma, chronic pain, recurrence, et al.

Study details

Official title
A Comparative Study of 3-point With 1-point Mesh Fixation in TAPP for Inguinal Hernia
Conditions
Interventions
  • Procedure: Lightweight mesh fixation in 3 points or 1 point
Sponsor
Nanchong Central Hospital
Collaborators
Guang'an people's hospital of Sichuan province; Pengan County People's Hospital; People's Hospital of Yilong County; Nanbu Hospital of County Chinese Medicine; Langzhong People's Hospital; Langzhong Traditional Chinese Medicine Hospital
Start date
2023-01-01
Primary completion
2025-10-10
Sex
All
Age range
from 18 Years to 80 Years
Results posted
No results posted in this snapshot
Countries
China
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Unilateral inguinal hernia according to preoperative physical examination and imaging examination. The inclusion criteria were as follows: primary inguinal hernia. Exclusion Criteria: * Age below 18 years or older than 80. recurrent hernia, incarcerated hernia, strangulated hernia, and other types of hernias. Patients not suitable for general anesthesia. Patients requiring open surgery; patients requiring emergency surgery Loss to follow-up or communication difficulties, or poor compliance.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06314152